Daily Newsletter

22 August 2023

Share with colleague
Subscribe

Daily Newsletter

22 August 2023

Share with colleague
Subscribe

Spotlight

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.

Latest news

Babylon Health’s downfall is exception in burgeoning telehealth market

Despite the recent demise of telehealth trailblazer Babylon Health, the telehealth market is expanding, especially in mental health services.

22 August 2023

Teleflex introduces updated Arrow ErgoPack Complete System in the US

The system includes a special combination of components for inserting CVCs in a top-down and left-to-right configuration.

22 August 2023

South Korean startup scores $1.2m grant for Alzheimer’s disease diagnostic

The grant by the South Korean Government will be distributed over three years to develop a blood test for Alzheimer's biomarkers.

22 August 2023

FDA approves Sentient’s Tixel to address crow’s feet

Sentient’s Tixel device has received FDA approval to target periorbital wrinkles.

22 August 2023

Nurami receives US FDA approval for resorbable repair graft

ArtiFascia integrates two layers of electrospun nanofibres to create biomimetic scaffolds and a non-porous barrier layer.

22 August 2023

Kernel begins cognitive decline study with neuroimaging technology

The study cohorts include individuals diagnosed with MCI and healthy controls, all aged over 55.

22 August 2023

FDA approves Exactech’s new Activit-E polyethylene

The company intends to deliver the first products at the start of the third quarter this year for select US customers.

22 August 2023

Generative AI set to transform the medical devices industry

GlobalData estimates the total AI market will be worth $908.7 billion in 2030, with a 35% CAGR (2022-30). Generative AI can improve personalized healthcare by collecting data from patients via wearable devices. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data and information through AI medical products could conflict with regulations around the globe.